New Drug Helps Shrink Inoperable Tumors in Kids
FRIDAY, March 20, 2020 (HealthDay News) — A new trial confirms that the drug selumetinib shrinks tumors in children suffering from neurofibromatosis type 1. The condition is characterized by changes in skin coloring and the growth of tumors along nerves in the skin, brain and other parts of the body.Continue Reading










